Zurcher Kantonalbank (Zurich Cantonalbank) Denali Therapeutics Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$39 Billion
Q2 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 43,587 shares of DNLI stock, worth $672,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,587

Previous 39,757 9.63%

Holding current value

$672,111

Previous $540,000 12.78%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$11.47 - $16.65 $43,930 - $63,769	3,830 Added 9.63%	43,587 $609,000
Q4 2024 Feb 07, 2025	BUY	$20.24 - $31.58 $203,169 - $317,000	10,038 Added 33.78%	39,757 $810,000
Q3 2024 Nov 07, 2024	BUY	$20.96 - $31.05 $69,503 - $102,961	3,316 Added 12.56%	29,719 $865,000
Q2 2024 Jul 29, 2024	BUY	$14.96 - $23.22 $20,525 - $31,857	1,372 Added 5.48%	26,403 $613,000
Q1 2024 Apr 25, 2024	BUY	$15.83 - $23.35 $35,522 - $52,397	2,244 Added 9.85%	25,031 $513,000
Q4 2023 Jan 30, 2024	BUY	$16.2 - $23.18 $34,149 - $48,863	2,108 Added 10.19%	22,787 $489,000
Q3 2023 Oct 25, 2023	BUY	$20.63 - $30.17 $43,818 - $64,081	2,124 Added 11.45%	20,679 $426,000
Q2 2023 Aug 07, 2023	BUY	$23.37 - $32.96 $40,593 - $57,251	1,737 Added 10.33%	18,555 $547,000
Q1 2023 May 08, 2023	BUY	$21.91 - $32.67 $98,595 - $147,015	4,500 Added 36.53%	16,818 $387,000
Q4 2022 Feb 01, 2023	BUY	$26.28 - $33.92 $21,286 - $27,475	810 Added 7.04%	12,318 $342,000
Q2 2022 Aug 09, 2022	BUY	$20.88 - $35.19 $2,463 - $4,152	118 Added 1.04%	11,508 $339,000
Q1 2022 Apr 21, 2022	BUY	$29.0 - $47.27 $12,934 - $21,082	446 Added 4.08%	11,390 $366,000
Q4 2021 Feb 01, 2022	BUY	$42.59 - $55.02 $90,205 - $116,532	2,118 Added 24.0%	10,944 $488,000
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $533 - $860	-11 Reduced 0.12%	8,826 $445,000
Q2 2021 Jul 30, 2021	SELL	$50.3 - $78.44 $22,433 - $34,984	-446 Reduced 4.8%	8,837 $693,000
Q1 2021 May 03, 2021	BUY	$53.8 - $81.53 $4,142 - $6,277	77 Added 0.84%	9,283 $530,000
Q4 2020 Jan 28, 2021	BUY	$36.89 - $93.56 $23,314 - $59,129	632 Added 7.37%	9,206 $771,000
Q2 2020 Jul 28, 2020	BUY	$16.01 - $28.82 $38,199 - $68,764	2,386 Added 38.56%	8,574 $207,000
Q1 2020 May 06, 2020	BUY	$14.2 - $27.98 $38,908 - $76,665	2,740 Added 79.47%	6,188 $108,000
Q4 2019 Jan 21, 2020	SELL	$14.4 - $19.99 $22,190 - $30,804	-1,541 Reduced 30.89%	3,448 $60,000
Q2 2019 Jul 30, 2019	SELL	$18.5 - $28.14 $88,041 - $133,918	-4,759 Reduced 48.82%	4,989 $104,000
Q1 2019 Apr 29, 2019	SELL	$17.99 - $24.65 $12,377 - $16,959	-688 Reduced 6.59%	9,748 $226,000
Q4 2018 Jan 25, 2019	BUY	$13.88 - $21.75 $17,169 - $26,904	1,237 Added 13.45%	10,436 $216,000
Q3 2018 Nov 09, 2018	BUY	$12.46 - $21.74 $24,907 - $43,458	1,999 Added 27.76%	9,199 $200,000
Q1 2018 May 03, 2018	BUY	$15.36 - $24.8 $110,592 - $178,560	7,200 New	7,200 $142,000

Others Institutions Holding DNLI

# of Institutions

247

Shares Held

135M

Call Options Held

148K

Put Options Held

15.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.07B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Denali Therapeutics Inc. Transaction History